R.D. Bulbrook
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Risks and Factors
- Cancer-related Molecular Pathways
Papers in
- Genetics 18
- Estrogen and related hormone effects 14
-
- Hormonal and reproductive studies 9
- Hormonal Regulation and Hypertension 4
- Adrenal Hormones and Disorders 3
- Co-authors
- J.L. Hayward (21 shared papers)L.V. Crawford (1 shared paper)D. Pim (1 shared paper)Jack Cuzick (2 shared papers)J Boreham (1 shared paper)Nicholas Wald (1 shared paper)Rosemary R. Millis (3 shared papers)M.A. Chaudary (3 shared papers)
- Journals
- The Lancet (12 papers)Journal of Endocrinology (10 papers)International Journal of Cancer (6 papers)British Journal of Cancer (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United KingdomNetherlandsJapan
In The Last Decade
R.D. Bulbrook
49 papers receiving 1.7k citations
R.D. Bulbrook's Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 478
- Oncology 774
- Biochemistry 137
- Genetics 528
- Pathology and Forensic Medicine 280
Countries citing papers authored by R.D. Bulbrook
This map shows the geographic impact of R.D. Bulbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.D. Bulbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.D. Bulbrook more than expected).
Fields of papers citing papers by R.D. Bulbrook
This network shows the impact of papers produced by R.D. Bulbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.D. Bulbrook. The network helps show where R.D. Bulbrook may publish in the future.
Co-authors
The 25 scholars most cited alongside R.D. Bulbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Hit paper breakdown → | 1982 | 377 |
| 2 | 1984 | 191 | |
| 3 | 1984 | 183 | |
| 4 | 1986 | 107 | |
| 5 | 1967 | 89 | |
| 6 | 1981 | 58 | |
| 7 | 1967 | 55 | |
| 8 | 1983 | 55 | |
| 9 | 1984 | 54 | |
| 10 | 1986 | 51 | |
| 11 | 1983 | 48 | |
| 12 | 1964 | 43 | |
| 13 | 1986 | 43 | |
| 14 | 1988 | 39 | |
| 15 | 1967 | 29 | |
| 16 | 1973 | 28 | |
| 17 | 1960 | 27 | |
| 18 | 1982 | 26 | |
| 19 | 1986 | 25 | |
| 20 | 1968 | 25 |
About R.D. Bulbrook
R.D. Bulbrook is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism, Oncology, Molecular Biology and Cancer Research, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (14 papers), Hormonal and reproductive studies (9 papers), Cancer Risks and Factors (9 papers), Breast Cancer Treatment Studies (6 papers), Hormonal Regulation and Hypertension (4 papers), Cancer Treatment and Pharmacology (3 papers), Adrenal Hormones and Disorders (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Cancer Research (478 citations), Oncology (774 citations), Biochemistry (137 citations), Genetics (528 citations) and Pathology and Forensic Medicine (280 citations). R.D. Bulbrook has collaborated with scholars based in United Kingdom, Netherlands and Japan. Frequent co-authors include J.L. Hayward, L.V. Crawford, D. Pim, Jack Cuzick, J Boreham, Nicholas Wald, Rosemary R. Millis, M.A. Chaudary, H. G. Kwa and D. Y. Wang. Their work appears in journals such as The Lancet, Journal of Endocrinology, International Journal of Cancer, British Journal of Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.